Effectiveness of a Vaccination Program in the Community ObGyn Setting
社区妇产科疫苗接种计划的有效性
基本信息
- 批准号:7583163
- 负责人:
- 金额:$ 22.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2010-08-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Although most adults realize the significance of immunizations for infant and child health, many do not recognize that vaccines offer a safe, cost-effective way to prevent morbidity and mortality among adolescents and adults. Nearly 45,000 US adults die each year from vaccine preventable diseases. The Institute of Medicine has called for the development of innovative strategies to improve vaccine coverage among adolescents and adults. Obstetrician-Gynecologists (Ob/Gyns) are uniquely positioned to immunize women of all ages against vaccine-preventable diseases. They are often the first point of contact for young women seeking care for reproductive health. Ob/Gyns function as primary care physicians, providing ? of all medical visits to women aged 17- 21 years. However, many Ob/Gyns do not routinely assess immunization status or administer vaccines in their offices. Commonly noted obstacles to providing vaccinations include cost/inadequate reimbursement, beliefs about their role in primary care, inadequate vaccine handling capability, lack of vaccine information, and safety/liability concerns in pregnancy. Our primary objective is to conduct a clinic-based study to develop and assess the effectiveness of a vaccination program for adolescent and adult women in the community Ob/Gyn setting. We propose to evaluate 4 Ob/Gyn offices in the Raleigh-Durham, NC area through in-depth, structured interviews of Ob/Gyn providers and office staff. In addition to details on current vaccine practices, medical record documentation, and encounter coding reimbursement, personnel will be queried on attitudes about vaccination, perceived barriers to an Ob/Gyn-based program, and ideas on overcoming such barriers. Findings will be used to design a program for adolescent and adult women, tailored for implementation in 2 of the 4 Ob/Gyn offices. Limited to vaccines for human papillomavirus and influenza & pertussis in pregnancy/postpartum, the program will cover a 12-month period, including 1 influenza season. Effectiveness of the intervention will be determined by pre- and post-program vaccination rates, program satisfaction, and willingness to continue the program. Detailed recording of all development and implementation strategies will allow for direct and immediate quantification of the resources and financial support required for vaccine program development and performance.
描述(由申请人提供):
尽管大多数成年人意识到免疫对婴儿和儿童健康的重要性,但许多人并不认识到疫苗为预防青少年和成人的发病率和死亡率提供了一种安全,成本效益的方式。每年有近45,000名美国成年人死于可预防疾病的疫苗。医学研究所呼吁制定创新策略,以改善青少年和成人的疫苗覆盖范围。产科医生(OB/Gyns)的唯一位置可以使各个年龄段的妇女免疫可预防疫苗的疾病。它们通常是寻求生殖健康护理的年轻妇女的第一个接触点。 ob/gyns充当初级保健医生,提供?在所有17至21岁妇女的医疗访问中。但是,许多OB/GYNS不会常规评估免疫状况或在其办公室中管理疫苗。通常注意到提供疫苗接种的障碍包括成本/报销不足,对其在初级保健中的作用的信念,疫苗处理能力不足,缺乏疫苗信息以及怀孕的安全/责任问题。我们的主要目标是进行基于诊所的研究,以开发和评估针对青少年和成年女性在社区OB/GYN环境中的疫苗接种计划的有效性。我们建议通过对OB/GYN提供商和办公室工作人员进行深入的结构化访谈来评估北卡罗来纳州罗利·杜勒姆(Raleigh-Durham)地区的4个OB/GYN办事处。除了有关当前疫苗实践,病历文档和遭遇编码补偿的详细信息外,人员还将在有关疫苗接种的态度,对基于OB/GYN的计划的障碍以及克服此类障碍的想法上查询人员。调查结果将用于设计针对青少年和成年女性的计划,该计划是在4个OB/GYN办公室中的2个中量身定制的。该计划仅限于怀孕/产后的人类乳头瘤病毒和流感和百日咳的疫苗,该计划将涵盖一个12个月的时间,包括1个流感季节。干预的有效性将取决于程序前和程序后疫苗接种率,计划满意度以及继续该计划的意愿。所有开发和实施策略的详细记录将允许直接和立即量化疫苗计划开发和绩效所需的资源和财务支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Geeta K. Swamy其他文献
702: Reduction of cesarean delivery surgical site infections using an evidence-based care bundle
- DOI:
10.1016/j.ajog.2016.11.436 - 发表时间:
2017-01-01 - 期刊:
- 影响因子:
- 作者:
Margaret S. Villers;Cami H. Thomas;Chad A. Grotegut;R. Phillips Heine;Geeta K. Swamy - 通讯作者:
Geeta K. Swamy
27: Single nucleotide polymorphisms in the oxytocin receptor and GRK6 are associated with oxytocin dosing requirements and labor outcomes
- DOI:
10.1016/j.ajog.2016.11.918 - 发表时间:
2017-01-01 - 期刊:
- 影响因子:
- 作者:
Chad A. Grotegut;Emily Ngan;Melanie E. Garrett;Allison E. Ashley-Koch;Geeta K. Swamy - 通讯作者:
Geeta K. Swamy
Low Dose Aspirin Counseling in Nulliparous Women
- DOI:
10.1016/j.ajog.2021.11.562 - 发表时间:
2022-01-01 - 期刊:
- 影响因子:
- 作者:
Sabrena Myers;Shauntell Luke;Khaila Ramey Collier;Tracy Truong;Kristin Weaver;Geeta K. Swamy;Sarahn M. Wheeler - 通讯作者:
Sarahn M. Wheeler
Factors associated with cesarean section in patients with COVID
- DOI:
10.1016/j.ajog.2021.11.705 - 发表时间:
2022-01-01 - 期刊:
- 影响因子:
- 作者:
Amanda M. Craig;Khaila Ramey Collier;Kristin Weaver;Sarahn M. Wheeler;Jennifer Gilner;Geeta K. Swamy;Brenna L. Hughes;Sarah K. Dotters-Katz - 通讯作者:
Sarah K. Dotters-Katz
Preterm birth rates and race disparities pre and post COVID vaccination
- DOI:
10.1016/j.ajog.2021.11.1029 - 发表时间:
2022-01-01 - 期刊:
- 影响因子:
- 作者:
Jennifer Cate;Amanda M. Craig;Miriam Estin;Kristin Weaver;Jennifer Gilner;Geeta K. Swamy;Brenna L. Hughes;Sarah K. Dotters-Katz;Sarahn M. Wheeler - 通讯作者:
Sarahn M. Wheeler
Geeta K. Swamy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Geeta K. Swamy', 18)}}的其他基金
NICHD Maternal-Fetal Medicine Units (MFMU) Network
NICHD 母胎医学中心 (MFMU) 网络
- 批准号:
9903408 - 财政年份:2011
- 资助金额:
$ 22.55万 - 项目类别:
Effectiveness of a Vaccination Program in the Community ObGyn Setting
社区妇产科疫苗接种计划的有效性
- 批准号:
7687452 - 财政年份:2008
- 资助金额:
$ 22.55万 - 项目类别:
相似国自然基金
疫苗接种后和自然感染后新冠病毒特异性T细胞应答的研究
- 批准号:32370945
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
运用机器学习算法探究免疫状态在异基因造血干细胞移植供者选择及疫苗接种中的临床价值及其分子机制解析
- 批准号:82370212
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
多维度解析疫苗接种后鱼类CD4+T细胞辅助B细胞产生抗体应答的机制
- 批准号:32373162
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
适龄儿童常见二类疫苗接种及时性与抗体滴度差异和VPD发病的层次贝叶斯时空模型研究
- 批准号:82360666
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
通过解除病毒特异性at-MBC的抑制状态改善反复接种新冠病毒疫苗后的体液免疫效果
- 批准号:82302066
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Einstein-Montefiore Clinical and Translational Science Award Hub
爱因斯坦-蒙蒂菲奥里临床和转化科学奖中心
- 批准号:
10622099 - 财政年份:2023
- 资助金额:
$ 22.55万 - 项目类别:
Cancer Control and Population Sciences Research Program
癌症控制与人口科学研究计划
- 批准号:
10625755 - 财政年份:2023
- 资助金额:
$ 22.55万 - 项目类别:
The Empilisweni Center for Women's Health - Advancing Implementation of Equitable Cervical Cancer Control
Empilisweni 妇女健康中心 - 推进公平宫颈癌控制的实施
- 批准号:
10738103 - 财政年份:2023
- 资助金额:
$ 22.55万 - 项目类别:
University of California, Davis: Human Papillomavirus Cancer Free (UCD: HPV Cancer Free)
加州大学戴维斯分校:无人类乳头瘤病毒癌症(UCD:无 HPV 癌症)
- 批准号:
10370548 - 财政年份:2023
- 资助金额:
$ 22.55万 - 项目类别:
Project 2 - Improving HIV prevention among postpartum women in Lilongwe, Malawi: the postpartum prevention package [Parent Title: PREVENTING INFANT INFECTIONS WITH IMPLEMENTATION SCIENCE IN MALAWI]
项目 2 - 改善马拉维利隆圭产后妇女的艾滋病毒预防:产后预防一揽子计划[父标题:在马拉维通过实施科学预防婴儿感染]
- 批准号:
10701196 - 财政年份:2023
- 资助金额:
$ 22.55万 - 项目类别: